| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif® in healthy Chinese subjects
|
Liu, Guangwen
|
|
|
149 |
6 |
p. 2585-2593
|
artikel
|
| 2 |
BDNF and its signaling in cancer
|
Malekan, Mohammad
|
|
|
149 |
6 |
p. 2621-2636
|
artikel
|
| 3 |
Bioenergy therapies as a complementary treatment: a systematic review to evaluate the efficacy of bioenergy therapies in relieving treatment toxicities in patients with cancer
|
Hauptmann, M.
|
|
|
149 |
6 |
p. 2607-2619
|
artikel
|
| 4 |
Cancer-associated inflammation: pathophysiology and clinical significance
|
Pęczek, Piotr
|
|
|
149 |
6 |
p. 2657-2672
|
artikel
|
| 5 |
Chemotherapy in combination with anti-PD-1 agents as adjuvant therapy for high-risk oral mucosal melanoma
|
Wu, Yunteng
|
|
|
149 |
6 |
p. 2293-2300
|
artikel
|
| 6 |
Chronological development of in-patient oncology in times of COVID-19: a retrospective analysis of hospitalized oncology and COVID-19 patients of a German University Hospital
|
Griewing, Sebastian
|
|
|
149 |
6 |
p. 2551-2558
|
artikel
|
| 7 |
Clinical characteristics and prognosis of patients with co-existing follicular lymphoma and diffuse large B-cell lymphoma components in rituximab era
|
Chen, Yi
|
|
|
149 |
6 |
p. 2311-2318
|
artikel
|
| 8 |
Clinical features and next-generation sequencing landscape of essential thrombocythemia, prefibrotic primary myelofibrosis, and overt fibrotic primary myelofibrosis: a Chinese monocentric retrospective study
|
Zhang, Lan
|
|
|
149 |
6 |
p. 2383-2392
|
artikel
|
| 9 |
Clinical significance of signal regulatory protein alpha and T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibition motif domain expression in undifferentiated pleomorphic sarcoma
|
Ishihara, Shin
|
|
|
149 |
6 |
p. 2425-2436
|
artikel
|
| 10 |
Combination therapy of doxorubicin and Sildenafil inhibits the growth of pediatric rhabdomyosarcoma
|
Urla, Cristian
|
|
|
149 |
6 |
p. 2513-2522
|
artikel
|
| 11 |
Combined diagnosis of multiparametric MRI-based deep learning models facilitates differentiating triple-negative breast cancer from fibroadenoma magnetic resonance BI-RADS 4 lesions
|
Yin, Hao-lin
|
|
|
149 |
6 |
p. 2575-2584
|
artikel
|
| 12 |
Complementary and alternative medicine application in cancer patients in Iran
|
Nejat, Nazi
|
|
|
149 |
6 |
p. 2271-2277
|
artikel
|
| 13 |
Comprehensive clinical evaluation of CAR-T cell immunotherapy for solid tumors: a path moving forward or a dead end?
|
Drougkas, Konstantinos
|
|
|
149 |
6 |
p. 2709-2734
|
artikel
|
| 14 |
Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer
|
Ralser, Damian J.
|
|
|
149 |
6 |
p. 2417-2424
|
artikel
|
| 15 |
Concurrent chemoradiotherapy combined with nimotuzumab in stage III–IVa nasopharyngeal carcinoma: a retrospective analysis
|
Cai, Zhuochen
|
|
|
149 |
6 |
p. 2327-2344
|
artikel
|
| 16 |
Diagnostic role of plasma ORM2 in differentiating prostate cancer from benign prostatic hyperplasia
|
Ge, Yuqiu
|
|
|
149 |
6 |
p. 2301-2310
|
artikel
|
| 17 |
Efficacy and safety of immuno-chemotherapy in patients with advanced non-small-cell lung cancer harboring oncogenic mutations: a multicenter retrospective study
|
Hata, Tae
|
|
|
149 |
6 |
p. 2475-2482
|
artikel
|
| 18 |
Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer
|
Kraus, Fabian B. T.
|
|
|
149 |
6 |
p. 2501-2511
|
artikel
|
| 19 |
Heterogeneous molecular behavior in liver tumors (HCC and CCA) of two patients with acute intermittent porphyria
|
Haverkamp, Thomas
|
|
|
149 |
6 |
p. 2647-2655
|
artikel
|
| 20 |
Heterozygous germline FLCN mutation in Birt–Hogg–Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report
|
Li, Jun
|
|
|
149 |
6 |
p. 2319-2325
|
artikel
|
| 21 |
Immunohistochemical analysis of a panel of cancer stem cell markers and potential therapeutic markers in pancreatic ductal adenocarcinoma
|
Ali, S. M. Adnan
|
|
|
149 |
6 |
p. 2279-2292
|
artikel
|
| 22 |
Implications for pelvic lymph node irradiation in definitive chemoradiotherapy of node negative muscle invasive bladder cancer based on predictive factors of clinicopathologic discrepancy
|
Saeedian, Arefeh
|
|
|
149 |
6 |
p. 2537-2542
|
artikel
|
| 23 |
Lymph node distribution in patients with remnant gastric cancer
|
Bafutto, Alexandre Augusto Ferreira
|
|
|
149 |
6 |
p. 2367-2374
|
artikel
|
| 24 |
Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis
|
Dai, Zhujiang
|
|
|
149 |
6 |
p. 2393-2416
|
artikel
|
| 25 |
Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis
|
Brown, Timothy J.
|
|
|
149 |
6 |
p. 2345-2354
|
artikel
|
| 26 |
Potent anti-tumor immune response and tumor growth inhibition induced by HER2 subdomain fusion protein in a mouse tumor model
|
Ghaedi, Mojgan
|
|
|
149 |
6 |
p. 2437-2450
|
artikel
|
| 27 |
Predictive role of galectin-3 for immune checkpoint blockades (ICBs) in advanced or metastatic non-small cell lung cancer: a potential new marker for ICB resistance
|
Kim, Jung Sun
|
|
|
149 |
6 |
p. 2355-2365
|
artikel
|
| 28 |
Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma
|
Marchenko, Sofya
|
|
|
149 |
6 |
p. 2523-2536
|
artikel
|
| 29 |
Progress in the treatment of urethral adenocarcinoma
|
Guo, Jiamin
|
|
|
149 |
6 |
p. 2693-2698
|
artikel
|
| 30 |
Role of vascular endothelial growth factor in radiotherapy resistance to esophageal squamous cell carcinoma
|
Li, Xin
|
|
|
149 |
6 |
p. 2543-2550
|
artikel
|
| 31 |
Safety of sequential immune checkpoint inhibitors after prior immune therapy
|
Awidi, Muhammad
|
|
|
149 |
6 |
p. 2375-2382
|
artikel
|
| 32 |
Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers
|
Dorman, Klara
|
|
|
149 |
6 |
p. 2463-2474
|
artikel
|
| 33 |
Targeting the (pro)renin receptor in cancers: from signaling to pathophysiological effects
|
Ouyang, Xin
|
|
|
149 |
6 |
p. 2595-2605
|
artikel
|
| 34 |
Ten years of AMNOG from an oncological perspective: new horizons and continuing expansion
|
Bartol, Arne
|
|
|
149 |
6 |
p. 2637-2645
|
artikel
|
| 35 |
The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study
|
Chen, Jinbin
|
|
|
149 |
6 |
p. 2491-2500
|
artikel
|
| 36 |
The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis
|
Ślusarczyk, Aleksander
|
|
|
149 |
6 |
p. 2673-2691
|
artikel
|
| 37 |
The negative impact of opioids on cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
|
Ju, Mingguang
|
|
|
149 |
6 |
p. 2699-2708
|
artikel
|
| 38 |
The prognostic role of PSMD14 in head and neck squamous cell carcinoma
|
Schnoell, Julia
|
|
|
149 |
6 |
p. 2483-2490
|
artikel
|
| 39 |
TKIs beyond immunotherapy predict improved survival in advanced HCC
|
Armstrong, Samantha
|
|
|
149 |
6 |
p. 2559-2574
|
artikel
|
| 40 |
Whole-exome sequencing of Indian prostate cancer reveals a novel therapeutic target: POLQ
|
Ravindran, Febina
|
|
|
149 |
6 |
p. 2451-2462
|
artikel
|
Tijdschrift beschrijving